Paul P. Shields
Chief Operating Officer at Enteris BioPharma, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Brian Zietsman | M | 60 |
Enteris BioPharma, Inc.
 Enteris BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Enteris BioPharma, Inc. operates as a clinical stage biopharmaceutical company. It offers formulation solutions built around its proprietary oral drug delivery technologies. The company was founded in 2013 and is headquartered in Boonton, NJ. | 11 years |
| Gary A. Shangold | M | 71 |
Enteris BioPharma, Inc.
Enteris BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Enteris BioPharma, Inc. operates as a clinical stage biopharmaceutical company. It offers formulation solutions built around its proprietary oral drug delivery technologies. The company was founded in 2013 and is headquartered in Boonton, NJ. | 4 years |
| Rajiv Khosla | M | 62 |
Enteris BioPharma, Inc.
Enteris BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Enteris BioPharma, Inc. operates as a clinical stage biopharmaceutical company. It offers formulation solutions built around its proprietary oral drug delivery technologies. The company was founded in 2013 and is headquartered in Boonton, NJ. | 4 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Joel A. Tune | M | 68 |
Enteris BioPharma, Inc.
Enteris BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Enteris BioPharma, Inc. operates as a clinical stage biopharmaceutical company. It offers formulation solutions built around its proprietary oral drug delivery technologies. The company was founded in 2013 and is headquartered in Boonton, NJ. | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 4 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Paul P. Shields
- Personal Network
